In the intricate world of pharmaceutical synthesis, the selection of high-quality intermediates is fundamental to the success of drug discovery and development. Benzeneacetonitrile, 3-(trifluoromethyl)-, identified by its CAS number 2338-76-3, stands out as a valuable building block, particularly for compounds incorporating fluorinated moieties. As a dedicated pharmaceutical material supplier, we provide this intermediate with the assurance of exceptional purity and consistent quality, critical for reproducible and efficient synthesis pathways.

The trifluoromethyl group (-CF3) present in Benzeneacetonitrile, 3-(trifluoromethyl)- is highly sought after in medicinal chemistry. Its introduction into drug candidates can significantly influence pharmacokinetic properties, such as metabolic stability, lipophilicity, and bioavailability. This makes the compound an indispensable tool for pharmaceutical researchers aiming to optimize drug efficacy and reduce side effects. Professionals looking to buy Benzeneacetonitrile, 3-(trifluoromethyl)- can rely on our commitment to providing materials that meet rigorous industry standards.

Our manufacturing capabilities allow us to produce Benzeneacetonitrile, 3-(trifluoromethyl)- with a purity of 99%, ensuring that it is free from impurities that could interfere with sensitive synthesis steps or affect the final API’s quality. The compound’s clear yellow-brown liquid form and well-defined physical properties, including a boiling point of 238.9 °C, make it easy to handle and integrate into various reaction protocols. We are a primary manufacturer in China, offering competitive pricing and a stable supply to support the ongoing needs of pharmaceutical companies worldwide.

For procurement managers and research scientists, securing a reliable source for essential chemical intermediates is a top priority. Our extensive experience in chemical manufacturing and export means we can efficiently meet demands for Benzeneacetonitrile, 3-(trifluoromethyl)- from laboratory scale to larger production batches. We encourage you to contact us to discuss your specific requirements and to obtain a quote for this critical pharmaceutical intermediate, ensuring your research and manufacturing pipelines remain robust and uninterrupted.